Company Overview of Nanogen Recognomics GmbH
Nanogen Recognomics is the combination of Nanogen’s NanoChip™ technology and Aventis R&T´s intellectual property and expertise in synthetic oligonucleotide chemistry and advanced molecular biology to develop new products and applications for the NanoChip™ System. Nanogen Recognomics GmbH is headquartered in Frankfurt, Germany. Nanogen Recognomics GmbH operates as a subsidiary of Accriva Diagnostics.
Key Executives for Nanogen Recognomics GmbH
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Nanogen Recognomics GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.